Komal Jhaveri
NPI 1871822288ActiveIndividual· Internal Medicine, Medical Oncology· New York, NY
Internal Medicine, Medical Oncology with Memorial Solid Tumor Group and 1 other group, practicing in New York, New York. Their prescriptions cost Medicare Part D more than their services did: $174,513 for 62 claims, against $24,257 paid for services in 2024. Hoffmann-La Roche Limited was the largest of 15 companies reporting payments in 2025, $162,904 in all, mostly consulting fees.
Overview
| NPI | 1871822288 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Sole proprietor | No |
| NPI issued | Dec 14, 2009 |
| Last updated in NPPES | Jun 16, 2015 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | 253683 | NY |
| Internal Medicine | 207R00000X | 253683 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 89 |
|---|---|
| Services billed | 205 across 9 procedure codes |
| Paid by Medicare | $24,257 |
Part D prescriptions in 2024
| Prescriptions (claims) | 62 · 143 30-day fills |
|---|---|
| Patients | 28 |
| Total drug cost | $174,513 |
| Generic share | 87% of claims |
Education and affiliations
| Graduation year | 2001 |
|---|---|
| Medicare specialty | Medical Oncology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical groups
- Memorial Solid Tumor GroupNew York, NY · 234 clinicians
- Memorial Developmental Chemo GroupNew York, NY · 48 clinicians
Industry payments (Open Payments)
- 2025$162,904 · 85 payments from 15 companies
- 2024$175,491 · 94 payments from 14 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Hoffmann-La Roche Limited | $35,278 | 7 |
| Eli Lilly and Company | $34,225 | 22 |
| Astrazeneca Pharmaceuticals LP | $24,115 | 21 |
| Gilead Sciences, Inc. | $14,302 | 3 |
| Astrazeneca Uk Limited | $13,941 | 7 |
What the 2025 payments were for
- Consulting Fee$140,828 · 56 payments
- Travel and Lodging$13,151 · 8 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$7,742 · 5 payments
- Food and Beverage$1,051 · 15 payments
- Education$130.54 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Medical Oncology providers in New York
- 1083988513
- 1871784504
- 1295706869
- 1912978487
- 1245945021
- 1316406879
- 1588789341
- 1972877546
- 1972835874
- 1104281245
- 1134190168
- 1598146227
All Internal Medicine, Medical Oncology providers in New York →